Doctors usually treat mantle cell lymphoma using chemotherapy and most times, rituximab. However, there are now new treatment options being used. These new treatments have been shown to be effective in the treatment of mantle cell lymphoma. Some of these new treatments include:
Acalabrutinib uses an immunosuppressive drug like rituximab to kill cancer cells. The drug works by inhibiting the receptor for the human masticle cell tumor. This drug is taken as a pill once a day. Also, this drug is given via injection. Although, many people do not like the taste of acalabrutinib, doctors prefer it to the oral forms of this medication. This type of mantle cell lymphoma treatment has not yet been approved by the FDA.
Another type of mantle cell lymphoma treatment is lenalidomide. This drug, also known as platinum, kills off the cancerous cells but has not been approved by the FDA as of yet. Lenalidomide is administered as a single shot, through the vein. This type of mantle cell lymphoma treatment has not yet been approved by the FDA.
Another type of mantle cell lymphoma treatment using an immunosuppressant is done with the help of cyclophosphamide or cyclooxygenase (COX). A special enzyme is introduced into the body to stop the excess production of the harmful amino acid L-Cysteine that causes blood cancers. To administer this form of therapy, a single shot of the drug is given intravenously through the vein. This form of acalabrutinib approval has not yet been approved by the FDA.
A special nebulizer is used for the administration of acalabrutinib. A nebulizer is a respiratory aid that can deliver the medicine straight into the lungs. The nebulizer combines a tablet and an aerosol spray into one convenient gadget. It is especially useful for patients who have difficulty swallowing a capsule or who have breathing difficulties after delivering a dose of the blood cancer drug acalabrutinib. However, nebulizers cannot be utilized for patients with a lung condition that could interfere with breathing through the mouth.
However, when you are diagnosed with mantle cell lymphoma it is comforting to know that if you are diagnosed early, there is a good chance you will at least be given the care and treatment necessary with acalabrutinib to beat it. By the same token, it is reassuring to know that if you are already diagnosed, your cancer has a good chance of responding well to treatment and staying on the path toward recovery.
One of the latest developments in the field of treating mantle cell carcinomas is the use of targeted therapy with an infusion of paclitaxel. This is an anticancer agent that works by preventing the formation of clumps of abnormal cells. Like all other antineoplastic drugs, it may cause some degree of bleeding, nausea, and an increased risk for infection. Click here for more details.